The rapid acceleration of the Transcatheter Aortic Valve Replacement (TAVR) Market is a success story anchored in technological progress and clinical evidence. The primary factor fueling this sustained Transcatheter Aortic Valve Replacement (TAVR) market growth is the shift in treatment guidelines based on robust clinical trial data. The demonstration of TAVR's non-inferiority (and in...